Hot Stocks

Hot stocks are not about hype. They emerge when powerful themes, policy shifts, and capital flows converge. InvestorPlace analysts track fast-moving market narratives, especially in technology, AI, and infrastructure, to identify stocks drawing outsized attention and explain what is really driving those moves.

Six Flags Earnings: SIX Stock Sinks 16% on Q4 Miss, Warnings

Six Flags (SIX) earnings for the amusement park company's fourth quarter of 2019 have SIX stock falling hard on Thursday.

E*Trade (ETFC) Stock Soars 23% on $13 Billion Morgan Stanley Deal

E*Trade (ETFC) stock is on the rise Thursday after announcing a massive $13 billion deal combining it with Morgan Stanley (MS).

China’s Coronavirus Brings the Qualcomm Quagmire Back in Focus

With Apple and China's coronavirus acting as near-term headwinds, investors can wait for better entry points into Qualcomm stock.

Soft Earnings Are a Problem for Walmart Stock and the Overall Market

Walmart stock has held up despite soft fourth-quarter results and guidance. But, the report signals risk for WMT and stocks as a whole.

Price Matters for Plug Power Stock

Plug Power is executing nicely, increasing confidence in its 5-year plan. But near-certain success is getting priced into PLUG stock.

At This Point, Even the Coronavirus Can’t Save MMM Stock

If you look at 3M’s healthcare revenues for all of 2019, they rose by 1.6% to $7.4 billion. That’s excluding its $6.7 billion acquisition of Acelity, a company that specializes in wound care. It contributed a 9.4% increase in sales. Overall, excluding acquisitions, divestitures, and currency, its organic revenues fell by 1.5% in 2019.

What if Qualcomm Stock Is Priced About Right?

Qualcomm stock enjoyed a stellar performance in 2019. But before diving in, it's wise to consider its present viability, especially with headwinds like the coronavirus at play.

Doing All the Right Things Isn’t Enough to Keep Driving Shopify Stock

Yet again, Shopify has shown that it can keep up the momentum, as seen with the latest earnings report. The result is that the stock continues its winning ways. But the valuation is getting frothy.

Hyatt Hotels Earnings: H Stock Dips 1% Lower Despite Q4 Beat

Hyatt Hotels (H) earnings for the hospitality company's fourth quarter of the year have H stock down after-hours Wednesday.

Zillow Earnings: ZG Stock Soars 9% on Strong Q4 Revenue Beat

Zillow (ZG,Z) earnings for the real estate company's fourth quarter of 2019 have ZG stock taking off after-hours Wednesday.

Boston Beer Earnings: SAM Stock Falls 8% on Q4 Report

Boston Beer (SAM) earnings for the alcohol company's fourth quarter of 2019 have SAM stock on the move after markets closed on Wednesday.

The Top Performing Sector in 2020 Will Be …

The future of healthcare will really start to take shape this year, and the next decade will bring advancements that we can only imagine in our wildest dreams.

Healthcare AI: 2 Transformative Technologies Can Make You Rich

The integration of AI will drive the future of healthcare. The train is taking off, but it’s not too late to climb on board.

Garmin Earnings: GRMN Stock Surges 7% on Positive Guidance

Garmin (GRMN) earnings for the GPS tech company's fourth quarter of the year have GRMN stock heading higher on Wednesday.

Bausch Health Earnings: BHC Stock Takes a Big 7% Hit on Mixed Q4

Bausch Health (BHC) earnings for the pharmaceutical company's fourth quarter of 2019 have BHC stock falling hard on Wednesday.

Sprint Stock Gets Another Big Boost as Merger Mania Sets In

Investors who purchased Sprint stock before a judge's Feb. 11 approval of the T-Mobile merger must be sitting pretty now.

Wingstop Earnings Q4: 5 Things for WING Stock Investors to Know

Wingstop (WING) earnings for the restaurant chain's fourth quarter of 2019 have WING stock down on Wednesday after missing EPS estimates.

It’s Time to Ditch Joyless Kraft Heinz Stock

Investors who bought an S&P 500 Index fund in mid-2017 would be much better off than Kraft Heinz stock holders today. How much longer are you willing to hold onto KHC?

Why Amarin Stock Is Getting No Love Early in 2020

Despite substantial attention on Amarin stock due to the underlying company’s Vascepa drug receiving FDA approval, shares haven’t looked great in 2020. Is this a discounted opportunity or a sign to stay away?